Home LiteratureArticle Details
PMID: 18252749 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain.

Gut ·Vol. 57 ·No. 7 ·2008-07-00 ·Pages 923-9

Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S

Abstract

The capsaicin receptor TRPV1 (transient receptor potential vanilloid type-1) may play an important role in visceral pain and hypersensitivity states. In irritable bowel syndrome (IBS), abdominal pain is a common and distressing symptom where the pathophysiology is still not clearly defined. TRPV1-immunoreactive nerve fibres were investigated in colonic biopsies from patients with IBS, and this was related to abdominal pain. Rectosigmoid biopsies were collected from 23 IBS patients fulfilling Rome II criteria, and from 22 controls. Abdominal pain scores were recorded using a validated questionnaire. TRPV1-, substance P- and neuronal marker protein gene product (PGP) 9.5-expressing nerve fibres, mast cells (c-kit) and lymphocytes (CD3 and CD4) were quantified, following immunohistochemistry with specific antibodies. The biopsy findings were related to the abdominal pain scores. A significant 3.5-fold increase in median numbers of TRPV1-immunoreactive fibres was found in biopsies from IBS patients compared with controls (p<0.0001). Substance P-immunoreactive fibres (p = 0.01), total nerve fibres (PGP9.5) (p = 0.002), mast cells (c-kit) (p = 0.02) and lymphocytes (CD3) (p = 0.03) were also significantly increased in the IBS group. In multivariate regression analysis, only TRPV1-immuno-reactive fibres (p = 0.005) and mast cells (p = 0.008) were significantly related to the abdominal pain score. Increased TRPV1 nerve fibres are observed in IBS, together with a low-grade inflammatory response. The increased TRPV1 nerve fibres may contribute to visceral hypersensitivity and pain in IBS, and provide a novel therapeutic target.

MeSH Terms
Abdominal Pain/metabolism,psychology Adult Aged Anxiety/metabolism Depression/metabolism Female Humans Immunoenzyme Techniques Inflammation Mediators/metabolism Intestinal Mucosa/metabolism Irritable Bowel Syndrome/metabolism,psychology Male Middle Aged Nerve Fibers/metabolism Neurons, Afferent/metabolism Pain Measurement/methods TRPV Cation Channels/metabolism
Chemicals
Inflammation Mediators TRPV Cation Channels TRPV1 protein, human
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Akbar A
Department of Gastroenterology, Imperial College London, UK.
Yiangou Y
Facer P
Walters J R F
Anand P
Ghosh S
References (45)
45 references, click to expand
  1. Role of infection in irritable bowel syndrome.
    J Gastroenterol. 2007 Jan;42 Suppl 17:41-7 PMID: 17238025
  2. Induction of vanilloid receptor channel activity by protein kinase C.
    Nature. 2000 Dec 21-28;408(6815):985-90 PMID: 11140687
  3. Colonic mucosal abnormalities associated with oral sodium phosphate solution.
    Gastrointest Endosc. 1996 May;43(5):463-6 PMID: 8726758
  4. The hospital anxiety and depression scale.
    Acta Psychiatr Scand. 1983 Jun;67(6):361-70 PMID: 6880820
  5. Increased mast cells in the irritable bowel syndrome.
    Neurogastroenterol Motil. 2000 Oct;12(5):449-57 PMID: 11012945
  6. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction.
    Gastroenterology. 1984 Aug;87(2):314-8 PMID: 6735075
  7. Changes in the rectal mucosa induced by hypertonic enemas.
    Dis Colon Rectum. 1978 May-Jun;21(4):227-36 PMID: 657932
  8. Impact of irritable bowel syndrome on quality of life.
    Dig Dis Sci. 1996 Nov;41(11):2248-53 PMID: 8943980
  9. Novel capsaicin (VR1) and purinergic (P2X3) receptors in Hirschsprung's intestine.
    J Pediatr Surg. 2001 Nov;36(11):1679-84 PMID: 11685701
  10. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.
    Gastroenterology. 2005 Mar;128(3):541-51 PMID: 15765388
  11. An inventory for measuring depression.
    Arch Gen Psychiatry. 1961 Jun;4:561-71 PMID: 13688369
  12. Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease.
    Gut. 2000 May;46(5):670-9 PMID: 10764711
  13. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia.
    Neuron. 2002 Sep 26;36(1):57-68 PMID: 12367506
  14. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters.
    Gastroenterology. 1992 Jun;102(6):1962-7 PMID: 1587415
  15. A role for inflammation in irritable bowel syndrome?
    Gut. 2002 Jul;51 Suppl 1:i41-4 PMID: 12077063
  16. Vanilloid (Capsaicin) receptors and mechanisms.
    Pharmacol Rev. 1999 Jun;51(2):159-212 PMID: 10353985
  17. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.
    Gastroenterology. 2004 Mar;126(3):693-702 PMID: 14988823
  18. Histopathological alterations in irritable bowel syndrome.
    Mod Pathol. 2006 Dec;19(12):1638-45 PMID: 17013373
  19. Psychological aspects of irritable bowel syndrome: comparisons with inflammatory bowel disease and nonpatient controls.
    Behav Res Ther. 1993 Mar;31(3):297-304 PMID: 8476404
  20. Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database.
    Aliment Pharmacol Ther. 2006 Sep 1;24(5):879-86 PMID: 16918893
  21. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats.
    Gastroenterology. 2007 Feb;132(2):615-27 PMID: 17258716
  22. Functional gastrointestinal disorders and mast cells: implications for therapy.
    Neurogastroenterol Motil. 2006 Jan;18(1):6-17 PMID: 16371078
  23. Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase.
    J Biol Chem. 2005 Apr 8;280(14):13424-32 PMID: 15691846
  24. Epidemiology of colonic symptoms and the irritable bowel syndrome.
    Gastroenterology. 1991 Oct;101(4):927-34 PMID: 1889716
  25. Visceral perception: inflammatory and non-inflammatory mediators.
    Gut. 2002 Jul;51 Suppl 1:i19-23 PMID: 12077058
  26. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.
    Gut. 2000 Dec;47(6):804-11 PMID: 11076879
  27. Irritable bowel syndrome in the general population.
    BMJ. 1992 Jan 11;304(6819):87-90 PMID: 1737146
  28. Activation of the mucosal immune system in irritable bowel syndrome.
    Gastroenterology. 2002 Jun;122(7):1778-83 PMID: 12055584
  29. Mechanisms of hypersensitivity in IBS and functional disorders.
    Neurogastroenterol Motil. 2007 Jan;19(1 Suppl):62-88 PMID: 17280586
  30. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?
    Gastroenterology. 2006 Feb;130(2):304-11 PMID: 16472586
  31. The capsaicin receptor: a heat-activated ion channel in the pain pathway.
    Nature. 1997 Oct 23;389(6653):816-24 PMID: 9349813
  32. Postinfectious irritable bowel syndrome.
    Gastroenterology. 2003 May;124(6):1662-71 PMID: 12761724
  33. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency.
    Lancet. 2003 Feb 1;361(9355):385-91 PMID: 12573376
  34. TRPV1 function in mouse colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine receptor activation.
    J Neurosci. 2004 Oct 27;24(43):9521-30 PMID: 15509739
  35. The short-form McGill Pain Questionnaire.
    Pain. 1987 Aug;30(2):191-197 PMID: 3670870
  36. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.
    Exp Dermatol. 2004 Mar;13(3):129-39 PMID: 14987252
  37. Study of visceral hypersensitivity in irritable bowel syndrome.
    Chin J Dig Dis. 2004;5(3):103-9 PMID: 15612244
  38. Vanilloid receptor 1 immunoreactivity in inflamed human bowel.
    Lancet. 2001 Apr 28;357(9265):1338-9 PMID: 11343743
  39. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome.
    Am J Gastroenterol. 2003 Jul;98(7):1578-83 PMID: 12873581
  40. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
    Gastroenterology. 2007 Jan;132(1):26-37 PMID: 17241857
  41. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.
    Gastroenterology. 2003 Dec;125(6):1651-9 PMID: 14724817
  42. Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice.
    Neurogastroenterol Motil. 2004 Dec;16(6):811-8 PMID: 15601431
  43. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form.
    Gut. 1991 Jan;32(1):73-9 PMID: 1991641
  44. Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats.
    Gut. 2003 May;52(5):713-9 PMID: 12692058
  45. Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution.
    Hum Pathol. 1998 Sep;29(9):972-8 PMID: 9744314
Article Info
Journal
Gut
Abbr.
Gut
ISSN
1468-3288
Published
2008-07-00
Epub
2008-00-05
Pages
923-9
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC2564830
Subset
IM
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com